Our Blog

Advanced imaging is one technology that could offer a real solution in predicting both the beneficial treatment response and the harmful side effects of immunotherapy treatments. At AIQ Solutions, we are working on technology that combines PET/CT scan data with advanced algorithms to better determine which patients will have a desirable response to immunotherapy.

AIQ Solutions has a software technology platform, driven by artificial intelligence, that can robustly quantify spatiotemporal heterogeneity of treatment response and pharmacodynamic effects

Precision Medicine is an exciting field, but it needs help growing and becoming more applicable in a clinical setting. We're evaluating some of the challenges that precision medicine is facing today and how technologies such as AIQ Solutions can help enhance the practice.

It's generally accepted that not all patients respond to the same therapy the same way. New technology is allowing physicians and study principle investigators to understand how different patients respond to a given therapy to improve patient outcomes.

AIQ has developed a medical device technology platform, based on advanced analytics, including artificial intelligence that automatically provides quantitative, lesion by lesion treatment response information.

AIQ Solutions will be exhibiting at ASCO Genitourinary Cancers Symposium on February 14th and 15th, 2020, at the Moscone West Building in San Francisco.

AIQ Solutions raises $3.2M in Series A round to continue development and commercialization of medical software platform

AIQ Solutions has contributed to a poster presentation at the 2019 ASCO Annual Meeting in Chicago, IL, held May 31-June 4, 2019.

AIQ Solutions has been chosen to present during Startup Stadium at BIO 2019, Wednesday, June 5, 2019.